Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy

Clinical and Experimental Nephrology

Volumn 19, Issue 4, 2015, Pages 653-660

  Akiyama, Shin’ichi ^a   Akiyama, Mari ^a   Imai, Enyu ^b   Ozaki, Takenori ^a   Matsuo, Seiichi ^a   Maruyama, Shoichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nakayamadera Imai Clinic   (Japan)

Author keywords

Antibody; Japan; Membranous nephropathy; Phospholipase A2 receptor; Prevalence; Western blot

Indexed keywords

ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; SERUM ALBUMIN; UNCLASSIFIED DRUG; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE (PEOPLE); KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; RETROSPECTIVE STUDY; SECONDARY MEMBRANOUS NEPHROPATHY; WESTERN BLOTTING; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; IMMUNOLOGY; JAPAN; MIDDLE AGED;

AGED; ANTIBODIES; ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; JAPAN; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; RETROSPECTIVE STUDIES;

EID: 84940440146     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-014-1054-2     Document Type: Article

References (17)

1. Kitajima S, Furuichi K, Sakai N, Sagara A, Shinozaki Y, Toyama T, et al. Relapse and its remission in Japanese patients with idiopathic membranous nephropathy. Clin Exp Nephrol. 2014;. doi:10.1007/s10157-014-0987-9.
2. Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, et al. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16(6):903–20. doi:10.1007/s10157-012-0673-8.
3. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65(4):1400–7. doi:10.1111/j.1523-1755.2004.00518.x.
4. Ogi M, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Takaeda M, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis. 1994;24(3):427–36.
5. Honkanen E, Tornroth T, Gronhagen-Riska C, Sankila R. Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol. 1994;41(3):127–34.
6. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N. Long-term prognosis of membranous nephropathy. Clin Nephrol. 1986;25(2):64–9.
7. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. doi:10.1056/NEJMoa0810457.
8. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286–91. doi:10.2215/CJN.07210810.
9. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22(8):1543–50. doi:10.1681/ASN.2010111125.
10. Hoxha E, Kneissler U, Stege G, Zahner G, Thiele I, Panzer U, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82(7):797–804. doi:10.1038/ki.2012.209.
11. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364(7):616–26. doi:10.1056/NEJMoa1009742.
12. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS One. 2013;8(4):e62151. doi:10.1371/journal.pone.0062151.
13. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137–43. doi:10.1681/ASN.2010090967.
14. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26(8):2526–32. doi:10.1093/ndt/gfr247.
15. Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, et al. Evaluation of Anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study. Am J Clin Pathol. 2014;142(1):29–34. doi:10.1309/AJCP8QMOY5GLRSFP.
16. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2(6):1360–6. doi:10.2215/CJN.00980207.
17. Behnert A, Schiffer M, Muller-Deile J, Beck LH Jr, Mahler M, Fritzler MJ. Antiphospholipase A2 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy. J Immunol Res. 2014;2014:143274. doi:10.1155/2014/143274.